Atara Biotherapeutics, Inc. (ATRA) stock plunged in the after-hours; here is why?
Atara Biotherapeutics, Inc. (ATRA) declined in the after-hours market after announcing that Memorial Sloan Kettering Cancer Center (MSK) notified the FDA of a patient’s death in an ongoing study. ATRA is now at $12.12, down about 4% from yesterday’s close. At the closing of the previous trading on Friday, the stock price was $13.68. Approximately […]
Atara Biotherapeutics, Inc. (ATRA) stock plunged in the after-hours; here is why? Read More »